Evidence map›Paper›PMID 38543613›Full record

ArticleMicroorganisms2024

Characterization and Implications of IncP-2A Plasmid pMAS152 Harboring Multidrug Resistance Genes in Extensively Drug-Resistant

Li Mei, Yang Song, Xiao Liu, Kun Li, Xu Guo, Li Liu, Yang Liu, Zisis Kozlakidis, Io Hong Cheong, Duochun Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Mapping the knowledge landscape ofFrontiers in cellular and infection microbiology · 2026
    Review
  4. Review
  5. Pan-ResistantClinical medicine insights. Case reports · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Li MeiNational Pathogen Resource Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yang SongDivision of Infectious Disease, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Xiao LiuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Kun LiNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Xu GuoNational Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Li LiuNational Pathogen Resource Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Yang LiuNational Pathogen Resource Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Zisis KozlakidisInternational Agency for Research on Cancer, World Health Organization, 69007 Lyon, France.ORCID 0000-0002-3836-7209
Io Hong CheongState Key Laboratory of Systems Medicine for Cancer, Centre for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Duochun WangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.ORCID 0000-0003-2372-1532
Qiang WeiNational Pathogen Resource Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Chinese Center For Disease Control and Prevention · CNNational Institute for Communicable Disease Control and Prevention · CNCentre international de recherche sur le cancer · FRShanghai Jiao Tong University · CN

Funding

World Health Organization 001
6 · The paper itself

Abstract

Bacterial antimicrobial resistance (AMR) poses a significant global public health challenge. The escalation of AMR is primarily attributed to the horizontal gene transfer (HGT) of antibiotic resistance genes (ARGs), often facilitated by plasmids. This underscores the critical need for a comprehensive understanding of the resistance mechanisms and transmission dynamics of these plasmids. In this study, we utilized in vitro drug sensitivity testing, conjugation transfer assays, and whole-genome sequencing to investigate the resistance mechanism of an extensively drug-resistant (XDR)

Indexed as

antimicrobial resistance genes (ARGs)blaPERextensively drug-resistant (XDR)plasmidPseudomonas aeruginosarmtB

Identifiers

PMID38543613
PMCPMC10973999
OpenAlexW4392709535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.